SCHEMBL16644615

SCHEMBL16644615

Cc1ccc(-n2c3ccccc3c3cnccc32)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 4/20 0.47
MAOB P27338 4/20 0.47
ACHE P22303 1/20 0.47
CYP2D6 P10635 1/20 0.44
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
AOC3 Q16853 3/20 0.39
TOP2A P11388 1/20 0.39
ALOX12 P18054 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
CYP11B2 P19099 1/20 0.38
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37
CYP1A2 P05177 1/20 0.35
METAP2 P50579 1/20 0.35
CDK4 P11802 1/20 0.35
CDK6 Q00534 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16644614 0.91 AOC3 (0.41) MAOAMAOBACHECYP2D6KDM4E
SCHEMBL12394208 0.89 KDM4E (0.50) KDM4EATML3MBTL1ALOX12
SCHEMBL13980921 0.85 MAOA (0.49) MAOAMAOBACHECYP2D6KDM4E
SCHEMBL15394901 0.84 MAOA (0.48) MAOAMAOBACHECYP2D6KDM4E
SCHEMBL11978692 0.83 MAOA (0.50) MAOAMAOBACHECYP2D6KDM4E
SCHEMBL21453893 0.82 MAOA (0.43) MAOAMAOBACHECYP2D6KDM4E
SCHEMBL16640323 0.82 MAOA (0.43) MAOAMAOBACHECYP2D6KDM4E
SCHEMBL16644617 0.81 PDE4B (0.44) KDM4EATML3MBTL1HDAC3HDAC2
SCHEMBL16644618 0.81 L3MBTL1 (0.41) KDM4EATML3MBTL1
SCHEMBL13866634 0.80 MAOA (0.44) MAOAMAOBACHECYP2D6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170012224-A1 PLATINUM COMPLEXES AND DEVICES ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2017-01-12 US disclosed
US-9385329-B2 Platinum complexes and devices Arizona Board of Regents on behalf of Arizona State University and Universal Display Corporation (US) 2016-07-05 US disclosed
US-20150105556-A1 PLATINUM COMPLEXES AND DEVICES ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170012224-A1 PLATINUM COMPLEXES AND DEVICES OXA1L, OCIAD1, OCIAD2 MAOA 1850/4885MAOB 1214/4885ACHE 3544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.